Geyh et al. identified TGF-β1 signaling as a common cause of gene expressions in AML- and MDS-derived BM-MSCs; TGF-β1 can induce dysfunction of healthy BM-MSCs and damage their hematopoietic support ability. The gene discussed is TGFB1; the disease is acute myeloid leukemia.